(±)-MDMA and its enantiomers: potential therapeutic advantages of R(−)-MDMA

2017/12/16 by Elizabeth G. Pitts, Daniel W. Curry, Karly N. Hampshire +2 · 1 citation
Medicine · Pharmacology, Toxicology and Pharmaceutics · Psychology · #Cannabis and Cannabinoid Research #Forensic Toxicology and Drug Analysis #Psychedelics and Drug Studies

paper · doi:10.1007/s00213-017-4812-5

crossref issued 2017/12/16 · crossref published 2017/12/16 · crossref published-online 2017/12/16 · openalex publication_date 2017/12/16 · crossref created 2017/12/16 · crossref published-print 2018/02/01 · crossref deposited 2025/06/28 · openalex created_date 2025/10/10 · crossref indexed 2026/05/29 · openalex updated_date 2026/08/01

Citations

• Acute Psychological Effects of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”) are Attenuated by the Serotonin Uptake Inhibitor Citalopram
• The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)
• Use of classical and novel biomarkers as prognostic risk factors for localised prostate cancer: a systematic review

Cited by

• MDMA [wikipedia]